Royal UNIBREW A/S
Share buy-back program
Share buy-back program
COMPANY ANNOUNCEMENT NO 48/2025 - September 22, 2025
On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025.
The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016.
The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction value of the share buy-backs in the period will not exceed DKK 300m.
The following transactions on Nasdaq Copenhagen A/S have been made under the program:
| Number of Shares | Average purchase price DKK | Transaction value, DKK | |
| Accumulated, last announcement | 128,000 | 490.34 | 62,763,330 |
| September 15, 2025 | 10,000 | 491.57 | 4,915,700 |
| September 16, 2025 | 13,000 | 482.29 | 6,269,770 |
| September 17, 2025 | 12,000 | 484.36 | 5,812,320 |
| September 18. 2025 | 13,000 | 484.72 | 6,301,360 |
| September 19, 2025 | 12,000 | 482.14 | 5,785,680 |
| Total accumulated under the program | 188,000 | 488.55 | 91,848,160 |
With the transactions stated above Royal Unibrew owns a total of 791,042 shares, corresponding to 1.6% of the share capital. The total amount of shares in the company is 50,200,000, including treasury shares.
For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail: Flemming.Nielsen@royalunibrew.com
Telephone: +45 25 41 68 04
Encl.
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
MoonLake Immunotherapeutics AG28.9.2025 18:04:41 CEST | Press release
MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
2025 Modern Service Industry High-Quality Development Conference28.9.2025 08:54:30 CEST | Press release
Conference Held in West China's Chongqing to Promote Modern Service Industry Development
MT Højgaard Holding A/S27.9.2025 20:59:35 CEST | Press release
MT Højgaard Holding A/S: Major shareholder announcement
MT Højgaard Holding A/S27.9.2025 20:59:35 CEST | Pressemeddelelse
MT Højgaard Holding A/S: Storaktionærmeddelelse
ING Group26.9.2025 20:00:00 CEST | Press release
Update on ING’s exit from the Russian market
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom